Conference Co-chairs
Phillip Segal MD FRCPC
Assistant Professor, Department of Medicine, Division of Endocrinology & Metabolism
Clinician Teacher, University Health Network/Sinai Health
Dr. Phillip Segal graduated from the University of Alberta medical school and received further training in Internal Medicine and Endocrinology at the University of Toronto. In 2011, he was appointed as an assistant professor in the division of Endocrinology and Metabolism at the University of Toronto. Dr. Segal has achieved notable milestones in education, having completed the Master Teacher and cQUIPS quality improvement programs at the University of Toronto, along with the UHN-Rotman Leadership Development Program. Functioning as a clinician-teacher, Dr. Segal actively participates in teaching at all levels of the educational spectrum, from novice medical students to advanced endocrinology fellows. Dr. Segal serves as the medical director of the diabetes program at the University Health Network, and he holds the chair position for the QUEST Committee at the Banting & Best Diabetes Centre, underlining his commitment to advancing diabetes research and patient care.
Minna Woo MD FRCPC PhD
Director, Banting & Best Diabetes Centre
Ajmera Chair in Molecular Diabetes Research
Professor, Departments of Medicine, Institute of Medical Science, Immunology, and Pharmacology and Toxicology
Clinician Scientist, Division of Endocrinology & Metabolism, University Health Network/Sinai Health
Dr. Minna Woo is currently the Director of the Banting and Best Diabetes Centre at the University of Toronto and the Ajmera Chair in Molecular Diabetes Research at the Toronto General Hospital Research Institute. She is a staff endocrinologist at the Toronto General Hospital and a clinician scientist. She is a Professor of the Departments of Medicine and Immunology. Her laboratory focuses on molecular mechanisms that determine the pathogenesis of insulin resistance and related diseases using preclinical models, always examining the biological difference between males and females. She has published over 100 research articles, including Nature Medicine, Nature Immunology and Nature Communications. She has had numerous awards including Diabetes Canada and the Canadian Society of Endocrinology and Metabolism Young Investigator Awards. Her research is internationally recognized as a member elect of the American Society of Clinical Investigation.
Faculty Disclosure
It is the policy of the University of Toronto, Temerty Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs.
Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains but is not limited to relationships within the last FIVE (5) years with not-for-profit organizations, pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.
It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.